Acorda Therapeutics Inc (NASDAQ:ACOR)
| 0.575 Delayed Data As of Mar 31 |  -0.001 / -0.17%Today’s Change | 0.26 Today|||52-Week Range 1.71 | -25.00% Year-to-Date |
Latest ACOR News | Press Releases
No recent news for Acorda Therapeutics Inc.
Today’s Trading
| Previous close | 0.58 |
| Today’s open | 0.58 |
| Day’s range | 0.56 - 0.58 |
| Volume | 3,173 |
| Average volume (3 months) | 195,259 |
| Market cap | $14.6M |
Data as of 3:53pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +65.83% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +29.00% |
| Revenue growth (last year) | -8.14% |
| P/E ratio | NM |
| Price/Sales | 0.13 |
| Price/Book | 0.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RGLSRegulus Therapeutics... | +0.02 | +2.98% |
| INFIInfinity Pharmaceuti... | -0.03 | -16.50% |
| ALIMAlimera Sciences Inc | +0.34 | +19.10% |
| CLRBCellectar Bioscience... | +0.06 | +4.36% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Last reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $118.6M |
| Annual profit (last year) | -$65.9M |
| Net profit margin | -55.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
